CRYOPDP—centered around clinical trials, biopharma, and cell and gene therapies—augments DHL’s specialty pharma logistics ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief ...

Titled “State of the Industry—The Evolving Landscape of Healthcare Coverage and Access in 2025,” 1 the goal of the Access USA ...

A roundtable explores how patient access needs are being measured, while also discussing the value of affordability in ...

Jen Butler, chief commercial officer, Pleio, discusses the importance of balancing technology and personalization in patient ...

Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these ...

Jen Butler, chief commercial officer, Pleio, discusses how personalization, connectivity, technology, and proactive support ...

Jonathan James, CEO, Hope Charities, discusses the challenge of nonprofits securing sustainable funding while ensuring ...

Jonathan James, CEO, Hope Charities, discusses reimbursement challenges and barriers to care in patients requiring ...

Jen Butler, chief commercial officer, Pleio, discusses how the company’s GoodStart programs help patients navigate specialty ...

Jonathan James, CEO, Hope Charities, discusses how, despite policy advancements, millions of people still face barriers to ...

1. AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing.